INVIVO THERAPEUTICS HOLDINGS CORP.
Healthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$10.7M | −$9.9M | −$9.1M | −$11.5M | −$12.8M | −$24.6M |
| Net income | −$10.5M | −$9.9M | −$9.1M | −$11.8M | −$23.4M | −$26.7M |
| Total assets | $18.8M | $21.8M | $21.9M | $9.3M | $18.4M | $14.0M |
| Total liabilities | $3.1M | $3.7M | $2.7M | $3.7M | $2.3M | $3.9M |
| Equity | $15.7M | $18.1M | $19.2M | $5.6M | $16.1M | $10.1M |
| EPS (diluted) | $-6.83 | $-7.48 | $-1.31 | — | — | — |
| Shares out. | 34.3M | 34.2M | 591,711 | 9.3M | 38.1M | 32.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −66.6%
- Return on assets
- −55.7%
- Return on capital (ROCE)
- −65.1%
- Liabilities / assets
- 16.3%
- Debt / equity
- 0.20×
- Book value / share
- $0.46
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -36.21distress
- Accruals / assets
- −0.0%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jun 29, 2007
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeFeb 6, 2024
- Bankruptcy or receivershipFeb 1, 2024
- Shareholder voteJan 3, 2024
- Delisting / listing-standard noticeDec 1, 2023
- Item 5.08Nov 30, 2023
- Director / officer changeNov 22, 2023
- Terminated a material agreementSep 1, 2023
- Other material eventMar 9, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 25-NSEMar 21, 2024
- SC 13G/AFeb 14, 2024
- SC 13G/AFeb 13, 2024
- 4/APRIMARY DOCUMENTFeb 7, 2024
- 4PRIMARY DOCUMENTFeb 7, 2024
- SC 13G/ABRICE FOOSEFeb 6, 2024
- 8-KFORM 8-KFeb 6, 2024
- 8-KFORM 8-KFeb 1, 2024
- 8-KFORM 8-KJan 3, 2024
- ARSDec 5, 2023
- DEF 14ADec 5, 2023
- 8-KFORM 8-KDec 1, 2023
- 8-KFORM 8-KNov 30, 2023
- 8-KFORM 8-KNov 22, 2023
- 10-QNov 8, 2023
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.